Early experience with a simplified technique for transcatheter closure of the patent foramen ovale
S Kutty, DG Nykanen, EM Zahn - Heart, Lung and Circulation, 2009 - Elsevier
BACKGROUND: Although generally safe, transcatheter patent foramen ovale (PFO) closure
typically involves catheter exchanges and manipulations within the left atrium (LA) that may …
typically involves catheter exchanges and manipulations within the left atrium (LA) that may …
Percutaneous closure of patent foramen ovale without echocardiographic guidance.
P Jamshidi, A Wahl, S Windecker… - Indian Heart …, 2007 - europepmc.org
Background A percutaneous patent foramen ovale (PFO) closure procedure includes
transesophageal or intracardiac echocardiographic guidance at many centers. We …
transesophageal or intracardiac echocardiographic guidance at many centers. We …
A novel system for transcatheter closure of patent foramen ovale: clinical and echocardiographic outcome comparison with other contemporary devices
K Darsaklis, X Freixa, A Asgar, R Ibrahim… - Canadian Journal of …, 2014 - Elsevier
Background Effective closure performance for patent foramen ovale (PFO) has been
suggested to be one of the factors that plays a relevant role in future clinical outcomes after …
suggested to be one of the factors that plays a relevant role in future clinical outcomes after …
Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome
MC Post, KV Deyk, W Budts - Acta cardiologica, 2005 - Taylor & Francis
Introduction—Patent foramen ovale (PFO) has been identified as a source of paradoxical
embolism and cryptogenic stroke. Low recurrence rates of ischaemic stroke after …
embolism and cryptogenic stroke. Low recurrence rates of ischaemic stroke after …
[HTML][HTML] Transcatheter Closure of Patent Foramen Ovale: Not Always an “Open or Shut” Case
Effectiveness of PFO closure is typically assessed using bubble contrast during transthoracic
echocardiography. An abnormal RLS after PFO closure could be the result of incomplete …
echocardiography. An abnormal RLS after PFO closure could be the result of incomplete …
[PDF][PDF] Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients
J Stinimann - Swiss medical weekly, 2008 - smw.ch
Background: Percutaneous closure of patent foramen ovale (PFO) is generally performed
using intra-procedural guidance by transoesophageal (TEE) or intracardiac (ICE) …
using intra-procedural guidance by transoesophageal (TEE) or intracardiac (ICE) …
Transcatheter Closure of Patent Foramen Ovale: Devices and Technique.
MJ Price - Interventional Cardiology Clinics, 2017 - europepmc.org
Transcatheter closure of a patent foramen ovale (PFO) reduces the risk of recurrent
cryptogenic stroke compared with medical therapy. PFO closure is a prophylactic procedure …
cryptogenic stroke compared with medical therapy. PFO closure is a prophylactic procedure …
[HTML][HTML] Seven-year follow-up of percutaneous closure of patent foramen ovale
N Mirzada, P Ladenvall, PO Hansson, MC Johansson… - IJC Heart & Vessels, 2013 - Elsevier
Background Observational studies favor percutaneous closure of patent foramen ovale
(PFO) over medical treatment to reduce recurrent stroke while randomized trials fail to …
(PFO) over medical treatment to reduce recurrent stroke while randomized trials fail to …
Transcatheter PFO closure with GORE® septal occluder: Early and mid‐term clinical results
G Butera, A Saracino, P Danna… - Catheterization and …, 2013 - Wiley Online Library
Background Transcatheter closure of patent foramen ovale (PFO) is a widespread
procedure. However the “quest” for the ideal device is still ongoing. Here we present the …
procedure. However the “quest” for the ideal device is still ongoing. Here we present the …
Results of percutaneous closure of patent foramen ovale with the GORE® septal occluder
M Knerr, S Bertog, L Vaskelyte… - Catheterization and …, 2014 - Wiley Online Library
Objective The aim of this study was to evaluate the safety and efficacy of the GORE® Septal
Occluder (GSO) at 1‐, 6‐, and 12‐month follow‐up in patients with a clinical indication for …
Occluder (GSO) at 1‐, 6‐, and 12‐month follow‐up in patients with a clinical indication for …